Antimitotic Agents: all 5,052 studies that test it
Page 20 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic CancerCompletedNCT06538207Phase 1
- A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung CancerCompletedNCT06532032Phase 1/2
- Efficacy and Safety of Colchicine After PCIActive, not recruitingNCT06472908Phase 3
- Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast CancerActive, not recruitingNCT06458413Phase 2
- Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort StudyActive, not recruitingNCT06451302Not applicable
- Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With ChemotherapyActive, not recruitingNCT06449209Phase 2
- A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerActive, not recruitingNCT06445400Phase 2
- Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion ApproachesCompletedNCT06426537Early Phase 1
- TIP Regimen Combined With Toripalimab Neoadjuvant Therapy for Locally Advanced Penile CancerCompletedNCT06415318Phase 2
- Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal AdenocarcinomaWithdrawnNCT06398587Phase 2
- CHemotherapy And Stool Transplant in PDAC (CHASe-PDAC)Active, not recruitingNCT06393400Phase 1
- EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT06390059Phase 2
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)Active, not recruitingNCT06382142Phase 3
- A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02)Active, not recruitingNCT06382129Phase 3
- A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)Active, not recruitingNCT06378177Phase 2
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)Active, not recruitingNCT06343948Phase 3
- Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery DiseaseCompletedNCT06342609Phase 4
- FID-007 Followed by Standard of Care Surgery in Head and Neck CancerTerminatedNCT06338657Phase 1
- FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT06332092Phase 2
- A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerActive, not recruitingNCT06317311Phase 2
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)Active, not recruitingNCT06304974Phase 3
- Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)WithdrawnNCT06280976Phase 4
- A Study of KK2269 in Adult Participants With Solid TumorsActive, not recruitingNCT06266299Phase 1
- A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerActive, not recruitingNCT06251973Phase 2
- Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal CancerActive, not recruitingNCT06247956Phase 2
- Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery DiseaseCompletedNCT06212271Early Phase 1
- Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)CompletedNCT06203977Phase 2
- A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic CancerTerminatedNCT06199466Phase 1
- A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)Active, not recruitingNCT06118333Phase 3
- Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck CancerTerminatedNCT06110195Phase 1
- Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine CancerActive, not recruitingNCT06107868Phase 1
- Different Doses of Colchicine on hsCRPCompletedNCT06078904Phase 4
- The Seven Trial: Exploiting the Unfolded Protein ResponseTerminatedNCT06076837Phase 1
- To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLActive, not recruitingNCT06072131Phase 3
- PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCCompletedNCT06062602Early Phase 1
- Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + AbirateroneWithdrawnNCT06060587Phase 2
- The Effect of Colchicine on Inflammation in ACS PatientsCompletedNCT06054100Phase 3
- Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the HandsWithdrawnNCT06026358Phase 4
- Residual Inflammatory Risk-Guided colcHicine in Elderly TrialStatus unknownNCT06025071Phase 4
- Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)Active, not recruitingNCT06009861Phase 2
- A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic CancerActive, not recruitingNCT05984602Phase 1
- Effect of Low Dose of Colchicine on Platelet ReactivityCompletedNCT05956145Not applicable
- Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 DiabetesActive, not recruitingNCT05949281Phase 2
- A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell CarcinomaActive, not recruitingNCT05943795Phase 3
- Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II TrialStatus unknownNCT05942573Phase 2
- Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical TrialCompletedNCT05930002Not applicable
- A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBCActive, not recruitingNCT05918133Phase 1/2
- Probiotic and Colchicine in COVID-19CompletedNCT05911022Not applicable
- Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic CancerCompletedNCT05908747Phase 2
- AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung CancerActive, not recruitingNCT05904379Phase 1/2
- Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the FaceCompletedNCT05900258Phase 4
- A Study of PM8002 in Combination With Chemotherapy in Patients With SCLCActive, not recruitingNCT05879068Phase 2
- GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic CancerWithdrawnNCT05861336Phase 2
- Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)Active, not recruitingNCT05856695Phase 2
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and ColchicineActive, not recruitingNCT05850091Phase 4
- CHildren Treated With Vincristine: A Trial Regarding Pharmacokinetics, DNA And Toxicity of Targeted Therapy In Pediatric Oncology Patients.Status unknownNCT05844670Phase 4
- Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell CarcinomaTerminatedNCT05834543Phase 1/2
- Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer PatientsStatus unknownNCT05833919Phase 2
- AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine CancerWithdrawnNCT05826015Phase 1
- Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)Active, not recruitingNCT05816499Phase 1/2
- PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With EribulinActive, not recruitingNCT05810870Phase 2
- Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCCCompletedNCT05807542Phase 2
- The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma PatientsStatus unknownNCT05802992Phase 3
- Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous AngiosarcomaWithdrawnNCT05799612Phase 1
- Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell CarcinomaStatus unknownNCT05798793Phase 3
- The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and ObesityCompletedNCT05785429Not applicable
- R-CMOP in Patients With Primary Diffuse Large B-cell LymphomaStatus unknownNCT05777369Not applicable
- Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.Status unknownNCT05749575Phase 2
- Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast CancerStatus unknownNCT05749016Phase 2
- Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast CancerStatus unknownNCT05747326Phase 2
- Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)Status unknownNCT05739929Phase 3
- Hydroxychloroquine in Colchicine-Resistant Glucocorticoid-Dependent Idiopathic Recurrent PericarditisStatus unknownNCT05737680Phase 3
- The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion InjuryStatus unknownNCT05734612Phase 3
- Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary SyndromeCompletedNCT05726019Phase 2
- Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT05721755Phase 3
- Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaActive, not recruitingNCT05715931Phase 2
- Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With ImmunotherapyTerminatedNCT05715229Phase 2
- Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical SurgeryActive, not recruitingNCT05713838Phase 2
- Proof of Concept Study to Access Superficial Basal Cell Carcinoma in AdultsCompletedNCT05713760Phase 2
- Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial InfarctStatus unknownNCT05709509Phase 4
- A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerStatus unknownNCT05705635Phase 2
- Phase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid TumorsActive, not recruitingNCT05700084Phase 1/2
- Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung AdenocarcinomaActive, not recruitingNCT05689671Phase 4
- CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic CancerSuspendedNCT05685602Phase 1
- DUMAS: Neo-Adjuvant Immunotherapy for Pancoast TumorsActive, not recruitingNCT05684276Phase 2
- Tolerability of Utidelone Capsule in Patients With Advanced Solid TumorsStatus unknownNCT05681000Phase 1
- Colchicine and Inflammation in Hemodialysis PatientsStatus unknownNCT05677555Phase 2
- Study With Various Immunotherapy Treatments in Participants With Lung CancerActive, not recruitingNCT05676931Phase 2
- A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC PatientsActive, not recruitingNCT05676203Phase 3
- Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast CancerSuspendedNCT05673200Phase 1
- Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid TumorsWithdrawnNCT05653661Phase 1
- Intravesical Gem/Doce in Patients With NMIBCActive, not recruitingNCT05644041Phase 2
- PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationCompletedNCT05639751Phase 1
- Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection FractionCompletedNCT05637398Phase 1/2
- Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic CancerStatus unknownNCT05634564Phase 2
- Study of Novel Treatment Combinations in Patients With Lung CancerActive, not recruitingNCT05633667Phase 2
- Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid TumorsActive, not recruitingNCT05620862Phase 1
- ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung CancersTerminatedNCT05616624Phase 1/2
- Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma PatientsStatus unknownNCT05611463Phase 2
- Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)Status unknownNCT05603065Phase 4